7 - nefritis intersticial aguda - aehr · e. sistémicas infecciones síndrome tinu 70 –75% 10...

51
NEFRITIS INTERSTICIAL AGUDA (NIA) Javier Reque Santivañez Hospital General Universitario de Castellón

Upload: others

Post on 28-Mar-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

NEFRITISINTERSTICIALAGUDA(NIA)

JavierReque SantivañezHo s p i t a l G e n e r a l U n i v e r s i t a r io d e C a s t e l l ó n

Page 2: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

FRACASORENAL AGUDO

Prerenal Parenquimatoso Postrenal

Necrosistubularaguda Intersticial Glomerulonefritis aguda

85% 5 %10%

NEngl JMed1996;334:1448-1460

Page 3: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

REGISTROESPAÑOLDEBIOPSIASSEN-MADRID2018

Biopsiasporfracasorenalagudo

18a45años

45a65años >65años

Page 4: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Haas M,SpargoBH,Wit EJ,MeehanSM:Etiologies andoutcome ofacute renalinsufficiency inolder adults:Arenal biopsy study of259cases.AmJKidney Dis 35:433–447,2000

Page 5: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 6: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

ETIOLOGÍA

Fármacos E.Autoinmune

E.Sistémicas Infecciones SíndromeTINU

Page 7: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

E.Autoinmune

E.Sistémicas

• Lupuseritematososistémico

• Sarcoidosis

• SíndromeSjögren

• EnfermedadIgG4(2003)• NTIHipocomplementémica(2001)

• Enfermedadporanticuerposantimembrana basaltubular

• Biopsy-proven acute interstitial nephritis,1993-2011:a case series.Muriithi AK,Leung N,Valeri AM,Cornell LD,Sethi S,FidlerME,Nasr SH AmJKidney Dis.2014;64(4):558.• Acute renalfailure ina64-year-oldwhiteman.Paueksakon P,ReveloM,LeeSM,Horn RG,FogoAB AmJKidney Dis.2000;36(3):669.

Page 8: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Infecciones

A S OC I A DA S C ON N I A

Legionella Poliomavirus

Leptospira Enterococus

Citomegalovirus (CMV) Escherichia coli

Streptococus Adenovirus

Micobacterium tuberculosis Espiroquetas (treponema)

Corinebacterium Diphteriae Hongos (histoplasmosis, coccidiodomicosis)

VirusdeEpstein Barr (EBV) Parásitos(Leishmania,Toxoplasma)

Yersinia

Page 9: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

ETIOLOGÍA

Fármacos E.Autoinmune

E.Sistémicas Infecciones SíndromeTINU

70– 75% 10– 20% 4– 10% 5 – 7%

Page 10: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Fármacos

ASOC I ADOS C ON N I A

Antiinflamatoriosnoesteroideos(incluidosCOX-2)PenicilinasycefalosporinasRifampicinaSulfonamidasCiprofloxacinoDiuréticos(deasaytiazidas)CimetidinaAlopurinolInhibidoresdebomba deprotonesIndinavir5-aminosalicilatos (Ej.Mesalasina)Inmunomoduladores (iplimumab,nivolumab,pembrolizumab,atezolizumab)

• Drug-Induced Acute Interstitial Nephritis.Moledina DG, Perazella MA. Clin JAmSoc Nephrol. 2017Dec7;12(12):2046-2049• Managing toxicities associatedwithimmune checkpoint inhibitors:consensus recommendations fromtheSociety forImmunotherapy ofCancer (SITC)Toxicity ManagementWorking

Group.JImmunother Cancer. 2017Nov21;5(1):95

Page 11: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 12: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Nat Rev Nephrol. 2018Sep;14(9):571-588.Sury K, Perazella MA, Shirali AC.Cardiorenal complications of immune checkpoint inhibitors.

Page 13: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 14: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 15: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 16: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Patient Antibiotics PPIs NSAIDs Corticosteroids OtherMedications1 pantoprazole aspirin prednisone albuterol,fluticasone,oxycodone2 hydrocortisone levothyroxine,escitalopram,finesteride,

clonazepam3 linezolid metoprolol,zolpidem,docusate45 trimethoprim/sulfamethox

azolepantoprazole prednisone levothyroxine,enoxaparin

6 omeprazole hydrocortisone levothyroxine,pregabalin,sodiumbicarbonate,fexofenadine,oxycontin,androgel

7 pantoprazole levothyroxine,enoxaparin,maalox,ranitidine8 ibuprofen910 ursodiol,oxycodone, lorazepam,ondansetron1112 ciprofloxacin omeprazole phenazopyridine,quinapril,tramadol,

glucosamine chondroitin

13 omeprazole

Page 17: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Patogenia

Page 18: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 19: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 20: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Manifestacionesclínicas

Page 21: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Manifestacionesclínicas

• Renalfailure andinterstitial nephritis due topenicillin andmethicillin.BaldwinDS,Levine BB,McCluskey RT,GalloGR.NEngl JMed.1968Dec;279(23):1245-52.

Page 22: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Manifestacionesclínicas

• Fiebre,rash yeosinofilia.

• Acute interstitial nephritis.AUPragaM,GonzálezE Kidney Int.2010;77(11):956• Duration ofTreatmentwith Corticosteroids andRecovery ofKidney Function inAcute Interstitial Nephritis.Fernandez-Juarez G,Perez JV,SpanishGroup for the Study ofGlomerularDiseases

(GLOSEN).Clin JAmSoc Nephrol.2018Dec 7;13(12):1851-1858.

Manifestación Praga KI20101 Fernandez-JuarezCJASN20182

Fiebre 36% 18%

Rash Cutáneo 22% 8%

Eosinofilia (> 500/mm3) 35% 25%

Fiebre +Rash +Eosinofilia 10% 3%

Page 23: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Duration ofTreatmentwith Corticosteroids andRecovery ofKidney Function inAcute Interstitial Nephritis.Fernandez-Juarez G,Perez JV,Caravaca-Fontán F,QuintanaL,Shabaka A,RodriguezE,Gadola L,deLorenzoA,CoboMA,Oliet A,SierraM,Cobelo C,IglesiasE,BlascoM,GaleanoC,Cordon A,OlivaJ,PragaM;SpanishGroup for the Study ofGlomerularDiseases (GLOSEN).Clin JAmSoc Nephrol.2018Dec 7;13(12):1851-1858.

Page 24: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Nat Rev Nephrol. 2010Aug;6(8):461-70.Perazella MA1,Markowitz GS.Drug-induced acute interstitial nephritis.

Page 25: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

(A) Nefritis intersticial inducida por Meticilina(B) Nefritis intersticial por otras drogas(C) Nefritis intersticial por AINEs

Page 26: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

• Acute interstitial nephritis.AUPragaM,GonzálezE Kidney Int.2010;77(11):956.

ManifestacionesFracasorenalagudo 100%

Fracasorenalagudo (diálisis) 40 %

Artralgias 45%

Fiebre 36%

Rash cutáneo 22%

Eosinofilia 35%

Microhematuria 67%

Macrohematuria 5%

Leucocituria 82 %

Proteinurianonefrótica 93 %

Proteinurianefrótica 2,5%

Síndrome nefrótico 0,8%

Page 27: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

¿Eosinofiluria?

Clin J Am Soc Nephrol 8: 1857–1862, 2013

Page 28: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 29: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Tiempodeinicio:

• 3a5días– Segundaexposiciónalfármaco

• Semanasameses- Primeraexposiciónalfármaco

BrJClinPharmacol.2007Dec;64(6):819–823.

Page 30: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Patología

Page 31: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 32: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 33: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 34: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Granuloma

Page 35: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Tratamiento

Page 36: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Tratamiento

•Discontinuacióndelfármaco

•Corticoides

•Otros

Page 37: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Tratamiento

Duration ofTreatmentwith Corticosteroids andRecovery ofKidney Function inAcute Interstitial Nephritis.Fernandez-Juarez G,Perez JV,SpanishGroup for the Study ofGlomerularDiseases(GLOSEN).Clin JAmSoc Nephrol.2018Dec 7;13(12):1851-1858.

Page 38: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 39: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

• Lamayoríadeloscasosdenefritisintersticialsonreaccionesalérgicas:• Soninducidasporfármacos• No esfenómenodosisdependiente• Sólounpequeñoporcentajedelospacientesdesarrollalaenfermedad• Remisióntrasdiscontinuacióndelfármaco• Remiteconlareutilizacióndelmismofármacoyunosimilar

• LoslinfocitosTjueganunpapelfundamentalenlaetiopatogenia:• Tiempode10a14días(síndromesmediadosporcélulasT)• ElinfiltradointersticialestácompuestoporlinfocitosT• EltestdeestimulacióndelinfocitosTespositivoenlamayoríadelospacientes.

Page 40: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Drug-specificproliferationofpatientsPBMC

Pt 1.

Positive proliferative response of PBMC to flucloxacillin

Pt 2

PBMC proliferative response to penicillin G

Pt 3

PBMC proliferative response to disulfiram

Involvement of Drug-Specific T cells in Acute Drug-Induced Interstitial Nephritis Spanou et al, JASN, 17: 2919, 2006

#Even though there were multi drug exposure, each patient elicited proliferative response to only one drug

Page 41: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 42: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 43: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 44: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 45: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 46: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 47: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor
Page 48: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Duration ofTreatmentwith Corticosteroids andRecovery ofKidney Function inAcute Interstitial Nephritis.Fernandez-Juarez G,Perez JV,SpanishGroup for the Study ofGlomerularDiseases (GLOSEN).Clin JAmSoc Nephrol.2018Dec 7;13(12):1851-1858.

Page 49: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Parallevaracasa:• La N IA d eb e fo rma r p a r t e d e l d i a gn ó s t i co d i f e r en c i a l d e t od o pa c i e n t e con

f r a ca s o r en a l a gu d o .

• C u a l q u i e r f á rma co p u ed e ca u s a r N IA , d eb e p r e s t a r s e e s p e c i a l a t e n c i ó n a

a n t i b i ó t i co s , a n t i n f l ama t o r i o s n o e s t e r o i d eo s e i n h i b i d o r e s d e b omba d e

p r o t o n e s .

• La t r i a d a c l á s i c a ( f i e b r e , r a s h y e o s i n o f i l i a ) e s mu y i n f r e cu en t e

• E l t i empo d e s d e e l i n i c i o d e l f á rma co h a s t a e l i n i c i o d e l cu a d ro e s mu y va r i a b l e

• E l u s o d e co r t i co i d e s ( p r e co z ) s e a s o c i a a me j o r p r o n ó s t i co

• C o n l a e v i d en c i a q u e d i s p o n emo s a c t u a lmen t e :

• Lo s b o l o s p o d r í a n NO s e r n e ce s a r i o s

• E l t r a t am i en t o e s t e r o i d eo n o d eb e r í a d u r a r ma s d e 1 2 s eman a s .

Page 50: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

Muchasgracias…

Page 51: 7 - Nefritis intersticial aguda - AEHR · E. Sistémicas Infecciones Síndrome TINU 70 –75% 10 –20% 4 –10% 5 –7%. Fármacos ... consensus recommendations from the Societyfor

• PragaM,GonzálezE.Acuteinterstitialnephritis.Kidney Int2010;77:956.• MuriithiAK, LeungN,ValeriAM,etal.Biopsy-provenacuteinterstitialnephritis, 1993-2011:a case series.AmJKidney

Dis2014;64:558.• TorpeyN,BarkerT,RossC.Drug-induced tubulo-interstitialnephritis secondarytoprotonpump inhibitors: experience

fromasingleUKrenalunit.NephrolDialTransplant2004;19:1441.• PragaM,SevillanoA,Auñón P,GonzálezE.Changesintheaetiology, clinicalpresentationandmanagementofacute

interstitialnephritis, anincreasinglycommoncauseofacutekidneyinjury.NephrolDialTransplant2015;30:1472.• CortazarFB,MarroneKA,TroxellML,etal.Clinicopathological featuresofacutekidney injuryassociatedwithimmune

checkpointinhibitors.Kidney Int2016;90:638.• StoneJH,ZenY,DeshpandeV.IgG4-relateddisease.NEnglJMed2012;366:539.• Gupta A,JothyS,SomervilleP,ZaltzmanJS.Hypocomplementaemic immunecomplextubulointerstitialnephritis.NDT

Plus2010;3:78.• MuriithiAK, LeungN,ValeriAM,etal.Clinicalcharacteristics,causesandoutcomesofacuteinterstitialnephritis inthe

elderly.KidneyInt2015;87:458.• ClarksonMR,GiblinL,O'ConnellFP,etal.Acuteinterstitialnephritis: clinicalfeaturesandresponsetocorticosteroid

therapy.NephrolDialTransplant2004;19:2778.• GonzálezE,GutiérrezE,GaleanoC,etal.Earlysteroidtreatmentimproves therecoveryofrenalfunction inpatients

withdrug-induced acuteinterstitialnephritis.Kidney Int2008;73:940.• Duration ofTreatment with Corticosteroids andRecovery ofKidney Function inAcute Interstitial Nephritis.Fernandez-

Juarez G,Perez JV,Spanish Group for the Study ofGlomerularDiseases (GLOSEN).Clin JAmSoc Nephrol.2018Dec7;13(12):1851-1858.